What Every General Surgeon Should Know About Breast Cancer
|
|
- Crystal McCormick
- 8 years ago
- Views:
Transcription
1 What Every General Surgeon Should Know About Breast Cancer Christina A. Finlayson, MD Associate Professor, Surgery Director, University of Colorado Hospital Breast Center
2 Outline How are we doing in the war against cancer? How do you order a mammogram? How do you stage breast cancer? What does medical oncology have to offer?
3 Change in the US Death Rates by Cause, 1950 & Rate Per 100, Heart Diseases Cerebrovascular Diseases Pneumonia/ Influenza Cancer
4 Five-year Relative Survival (%) during Three Time Periods By Cancer Site Site All sites Breast (female) Colon Lung and bronchus Melanoma Pancreas Prostate
5 Cancer Survival UCCC vs. Colorado 2006
6 Breast Cancer ,920 women diagnosed with invasive breast cancer 40,970 women will die from breast cancer 2 million women living who have been treated for breast cancer Risk of developing invasive breast cancer is 1 in 8 Risk of dying from breast cancer is 1 in 33 American Cancer Society, 2006
7 What Every Surgeon Should Know About Breast Cancer Radiology
8 Screening Guidelines for the Early Detection of Breast Cancer, American Cancer Society 2003 Patient is asymptomatic Insurance doesn t require a referral Doesn t require a physician order Mammographer is not on site
9 Screening Guidelines for the Early Detection of Breast Cancer, American Cancer Society 2003 Yearly screening mammograms are recommended starting at age 40 for women of average risk and continuing for as long as a woman is in good health
10 Mammogram Prevalence , USA All women 40 and older Prevalence (%) Women with less than a high school education Women with no health insurance Year
11 How Good is Mammography? 8 Randomized Controlled Trials 1960s % reduction in breast cancer mortality Sensitivity Mammography: 85% Physical Exam: 50% But, with the advances in equipment, film, and training, the sensitivity of mammography has
12 gone down. The actual sensitivity of screening mammography in clinical practice today is about 70% False negative mammogram: biopsy proven cancer within a year of a negative screening mammogram
13 Why is mammography doing worse? Prevalence cancers slow growing, large cancers in the population waiting to be found Incidence cancers develop more than one year after initial screen Interval cancers become clinically evident less than one year from last screen
14 Why is mammography doing worse? The sensitivity of mammography is determined by competing methods of diagnosis Women are more sensitive to detecting lumps and much more likely to bring them to medical attention Providers are also more aware
15 If mammography misses so much, is it worth screening? About 10 years after mammographic screening became widespread in the U.S., mortality from breast cancer started to drop.
16 USA mortality: USA - Age-adjusted Breast Cancer Mortality
17 If mammography misses so much, is it worth screening? We cannot be sure that the change is due to screening, but there is a good correlation:
18 Sweden has a tremendous yearly screening program: Sweden - Age-adjusted Breast Cancer Mortality
19 Great Britain also screens, but only every 3 years: U.K. - Age-adjusted Breast Cancer Mortality
20 while Denmark has no screening program: Denmark - Age-adjusted Breast Cancer Mortality
21 Is there a better screening test? No! Mammography is the best single screening test for women of average risk. Mammo + Physical Examination is a potent combination for screening
22 Screening Guidelines for the Early Detection of Breast Cancer, ACS 2003 Women at increased risk should talk with their doctors about the benefits and limitations of starting mammography screening earlier, having additional tests (i.e., breast ultrasound and MRI), or having more frequent exams.
23 Who are women at increased risk? Family history first degree relative Extended family history Previous biopsy Atypical hyperplasia LCIS BRCA1/BRCA2 (Radiation to chest wall)
24 Imaging options Mammography Ultrasound MRI, contrast enhanced
25 Mammography Gold-standard Multiple studies with mortality as end-point Decreases mortality from breast cancer by at least 25-50% Detection rate: 5-7/1000 for first mammogram 2-3/1000 for subsequent mammograms
26 Screening Ultrasound Ultrasound plus mammography finds more cancers than mammography alone Cancers seen by ultrasound are usually invasive Many false positives -- many extra biopsies U/S adds 1-2 cancer / 1000 screens Not covered by insurance for screening
27 Screening MRI Warner, E. JAMA, 2004
28 Screening BRCA1/2: 22 Cancers Detected Mammogram Ultrasound MRI Screened Sensitivity 38% 25% 85% Specificity 99.6% 95% 93% PPV 83% 23% 42% NPV 97% 96% 99% Warner, E. JAMA, 2004
29 ACS Guidelines for Breast Screening with MRI Recommend Annual MRI Screening (Based on Evidence) BRCA mutation First-degree relative of BRCA carrier, but untested Lifetime risk ~20 25% or greater, as defined by BRCAPRO or other models that are largely dependent on family history CA Cancer J Clin 2007
30 ACS Guidelines for Breast Screening with MRI Recommend Annual MRI Screening (Based on Expert Consensus Opinion) Radiation to chest between age 10 and 30 years Li-Fraumeni syndrome and first-degree relatives Cowden and Bannayan-Riley-Ruvalcaba syndromes and first-degree relatives CA Cancer J Clin 2007
31 ACS Guidelines for Breast Screening with MRI Insufficient Evidence to Recommend for or against MRI Screening Lifetime risk 15 20%, as defined by BRCAPRO or other models that are largely dependent on family history Lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH) Atypical ductal hyperplasia (ADH) Heterogeneously or extremely dense breast on mammography Women with a personal history of breast cancer, including ductal carcinoma in situ (DCIS) CA Cancer J Clin 2007
32 ACS Guidelines for Breast Screening with MRI Recommend Against MRI Screening (Based on Expert Consensus Opinion ) Women at <15% lifetime risk CA Cancer J Clin 2007
33 High Risk Screening: Cost Clinical Breast Exam $ Mammogram Bilateral MRI
34 Diagnostic Imaging
35 Diagnostic Imaging Workup of an abnormal screening mammogram Evaluation of a palpable abnormality or other breast complaint Evaluates characteristics of palpable mass Screens remainder of breast Imaging of breast cancer after diagnosis No emergency mammograms Radiologist available to interpret at time of imaging
36 Diagnostic Imaging Workup of an abnormal screening mammogram
37 BIRADS Assessments 0 Additional imaging evaluation needed 1 - Negative (routine screening) 2 - Benign (routine screening) 3 - Probably (6m f/u) 4- Suspicious (biopsy) 5 - Highly suspicious (biopsy) 6 Known, biopsy proven cancer (**New!!**)
38 CC MLO
39 Spot compression Magnification
40
41
42 Spot compression Magnification
43
44 Ultrasound evaluates a mammographic mass
45 Diagnostic Imaging Evaluation of a palpable abnormality or other breast complaint Evaluates characteristics of palpable mass Screens remainder of breast
46 Evaluation of a Palpable Abnormality Ultrasound is the mainstay Identifies over 99% of palpable cancers 99+% negative predictive value Not perfect (but close) Mammography Mainly useful for screening the remainder of the breast Required by COPIC A negative mammogram does not exclude cancer
47 Ultrasound of palpable mass
48 Diagnostic Imaging Imaging of breast cancer after diagnosis No emergency mammograms
49 Imaging after diagnosis
50 MRI Ipsilateral Breast Multifocal/Multicentric Pre-Contrast Post-Contrast
51 MRI Contralateral Breast MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer Lehman CD, et al NEJM Mar 29, 2007
52 MRI Contralateral Breast 25 institutions Minimum 50 MRIs Minimum 5 MRI biopsies 969 participants 30 cancers detected (3.1%) 10% false positive biopsies NPV 99%
53 MRI Contralateral Breast The current cost of MRI precludes its widespread use in general populations, but this imaging tool appears to improve the detection of cancer in women at increased risk, such as women with a recent diagnosis of breast cancer. Lehman et al, 2007
54 What Every Surgeon Should Know About Breast Cancer Lymph Node Staging
55 Predictors of Breast Cancer Survival Tumor size Lymph node metastasis
56 Predictors of Breast Cancer Tis noninvasive T1 < 2 cm Survival - Tumor size T2 greater than 2 cm but not greater than 5 cm T3 greater than 5 cm T4 chest wall, skin or inflammatory involvement
57 Predictors of Breast Cancer Survival Clinical staging Lymph node metastases cn0 no regional lymph node metastases cn1 positive lymph nodes, movable cn2 matted lymph nodes or positive internal mammary nodes cn3 positive infraclavicular nodes or internal mammary + axillary nodes or supraclavicular nodes
58 Predictors of Breast Cancer Survival Lymph node metastases Pathologic staging pn0 no regional lymph node metastases Single tumor cells or clusters < 0.2 mm pn0(i-) IHC negative pn0(i+) IHC positive pn0(mol-) RT-PCR negative pn0(mol+) RT-PCR positive
59 Predictors of Breast Cancer Survival Lymph node metastases pn1 positive regional nodes pn1a 1-3 positive axillary LN pn1b positive internal mammary nodes found by SNBx only pn1c = pn1a+pn1c
60 Predictors of Breast Cancer Survival Lymph node metastases pn2 positive regional nodes pn2a 4-9 positive axillary LN (at least one >2 mm) pn2b positive internal mammary nodes clinically apparent
61 Predictors of Breast Cancer Survival Lymph node metastases pn3 positive regional nodes pn3a >10 positive axillary LN (at least one >2 mm) or infraclavicular LN positive pn3b positive internal mammary nodes clinically apparent + pos axillary nodes pn3c positive supraclavicular nodes
62 Predictors of Lymph Node Metastasis Tumor size Lymphovascular invasion Tumor grade Patient age
63 Axillary Node Dissection
64 Axillary Node Dissection Lymphedema Parasthesias Pain Shoulder dysfunction
65 Definitions Axillary lymph node dissection
66 DefinitionsLymphatic Mapping
67 Definitions- Sentinel lymph node Lymph nodes identified by lymphatic mapping Clinically suspicious lymph nodes
68 Definitions- Sentinel lymph node biopsy
69 Consensus statements American Society of Breast Surgeons Institute for Clinical Systemic Improvement Canadian Steering Committee Consensus Conference Committee, Philadelphia German Society of Senology
70 Philadelphia Consensus Conference Sentinel node biopsy can replace routine axillary lymph node dissection for patients with no disease in the sentinel lymph node, with no further axillary treatment necessary. Schwartz GF, Giuliano AE, Veronesi U, et al Cancer, 2002
71 Specific situations Positive sentinel node biopsy Large tumors Inflammatory breast cancer Multicentric tumors DCIS Male breast cancer Pregnancy Internal mammary nodes Prior breast or axillary surgery
72 Positive sentinel lymph nodes 48% of patients with a positive sentinel lymph node will have additional disease found at axillary node dissection
73 Positive sentinel lymph nodes Immunohistochemistry upstages H&E negative lymph node status in 10% of patient pn0i+ Node deposits <0.2 mm are also pn0 No recommendation on axillary node dissection
74 Positive sentinel lymph nodes Micrometastases Node deposits 0.2<2.0 mm 20-35% will have additional positive LNs
75 Are there alternatives? Predictive models Axillary Radiation
76 Predictive models: Van Zee: Ann Surg Oncol, 2003
77 Axillary Radiation NSABP B-04 (1985) 818 patients clinically node negative MRM, TM+XRT, or TM alone 10 year axillary recurrence 1.4% (MRM) vs 3.1% (TM+XRT)
78 Axillary Dissection vs Radiation Where is the sentinel lymph node?
79 Surgeons view of the axilla
80 Radiation Oncologists view of the axilla
81 What we did: T4 2: Interest point viewed on AP DRR; vertebral body level and distance to inferior border of clavicle evaluated
82 What we did: 3: Interest point evaluated relative to previously designed tangential whole breast fields
83 Relationship of SLN to Tangent A: inside treated field - 78% B: under corner block - 12% C: outside of field - 10% A+B: if removed corner block - 90% A=78% C=10% B=12% Rabinovitch et al Center University of Colorado Cancer
84 SLN Position and Tangent Fields Key Findings/Conclusions Position of SLN relative to vertebral body level Ranges from T2-T7 most often opposite T4 on an AP view Relationship of SLN to tangents Outside of field 10% Under supero-posterior block 12% Within treated field 78% Relationship of SLN to clavicle Located inferior to clavicle in 94% 90% within treated field if remove corner block Most superior SLN was located 1.5 cm above base of clavicle Conclusions: Extension of tangents to 1.5 cm above bottom of clavicle would include SLN in 100% of patients Nearly all SLNs (94%) are located outside of traditional axillary radiotherapy fields If corner block removed, SLN within treated tangents 90%
85 Ongoing studies NSABP B-32 Randomized SN- patients to ALND vs. no further surgery EORTC Randomized SN+ patients to ALND vs. axillary radiation ACOSOG Z0011 Randomized SN+ patients to ALND vs. no further therapy (tangential breast radiation only)
86 Panel recommendations No ALND No recommendation ALND Negative SN IHC+ SN Micrometastases 0.2mm<2 mm Deposits <0.2 mm Macrometastases >2mm
87 Multicentric Tumors 10% of presenting breast cancers Tumor in more than one quadrant or separated by more than 2 cm Peritumoral vs. Subareolar injections SNBx performance similar to patients with unifocal disease
88 Ductal Carcinoma in Situ 5-15% are IHC positive SNBx if local treatment is mastectomy
89 Male Breast Cancer 1700 male breast cancers diagnosed annually Survival equivalent for women with similar stage Treatment of male breast cancer parallels treatment for women Unlikely the SNBx would be less accurate
90 Pregnancy Vital dye (lymphazurin) contraindicated Radiolabled colloids probably safe Insufficient data for specific recommendations
91 Internal mammary lymph nodes No survival advantage Rarely site of local recurrence Likelihood of SN site 10% Likelihood of metastatic involvement 1% Insufficient data for specific recommendations
92 Prior breast surgery Prior diagnostic or excisional breast biopsy not a contraindication Breast reduction may be contraindication for tumors in the lower or medial aspect of the breast Breast augmentation with submammary or subpectoral implants probably not a contraindication Minimal data
93 Conclusions Sentinel lymph node biopsy replaces axillary dissection in most situations An axillary dissection should be performed for most patients with positive sentinel nodes Morbidity from breast cancer treatment is decreased by limiting axillary dissection to patients with positive lymph nodes.
94 What Every Surgeon Should Know About Breast Cancer Medical Oncology
95 Medical Oncology Neoadjuvant chemotherapy Genetic profiling - Oncotype
96 Medical Oncology Neoadjuvant chemotherapy
97 Inflammatory breast cancer: T4d N3c M1
98 Rational of Neoadjuvant Chemotherapy What we learned from inflammatory breast cancer Local vs. systemic disease
99 Effect of Preoperative Chemotherapy on Local-Regional Disease in Women With Operable Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-18 Bernard Fisher, et al J Clin Oncol 1998
100 Effect of Preoperative Chemotherapy Disease Free Survival no effect Distant DFS no effect Overall Survival no effect Breast conservation 20% increase
101 Pre-NeoAdjuvant Chemotherapy Pre-contrast Post-contrast
102 Post-NeoAdjuvant Chemotherapy Pre-contrast Post-contrast
103 Neoadjuvant Chemotherapy Who should get it? Inflammatory breast cancer T3/4 tumors not amenable to immediate surgery Large tumor volume to breast volume ratio desiring breast conservation Clinically palpable lymph nodes
104 Neoadjuvant Chemotherapy What should they get? Chemotherapy Adriamycin? Herceptin? Antiendocrine therapy Aromatase Inhibitor
105 Medical Oncology Genetic profiling Oncotype
106 Oncotype Dx Produced by Genomic Health RNA from tumor extracted and purified RT-PCR of 21 genes Reverse transcription polymerase chain reaction Recurrence score calculated Based on proprietary Oncotype algorithm of gene expression
107 Oncotype Dx 21 Gene Assay
108 21 Gene Panel Analyzed by RT-PCR
109 What is sent in? 10 micron section of breast tumor from formalin fixed paraffin embedded tissue submitted x 6 1 H&E slide from same block
110 $3460
111 A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer Soonmyung Paik, M.D., Steven Shak, M.D., Gong Tang, Ph.D., Chungyeul Kim, M.D., Joffre Baker, Ph.D., Maureen Cronin, Ph.D., Frederick L. Baehner, M.D., Michael G. Walker, Ph.D., Drew Watson, Ph.D., Taesung Park, Ph.D., William Hiller, H.T., Edwin R. Fisher, M.D., D. Lawrence Wickerham, M.D., John Bryant, Ph.D., and Norman Wolmark, M.D. Volume 351: December 30, 2004 Number 27
112 Tumors from patients enrolled on 2 NSABP trials analyzed: NSABP B-14 ER+ LN- breast cancer Tamoxifen (n= 290) vs. Placebo (n=355) NSABP B-20 ER+ LN- breast cancer Tam (n=227) vs. Tam/CMF (n=434)
113 Recurrence Score Low Risk Intermed Risk High Risk Oncotype Score >31 10-yr distant recurrence rate 7% 14% 30%
114 Treatment benefit T amoxi f e n bene f i t by r ec ur r ence sc or e Pl acebo T amoxi f en R e c u r r e n c e s c o r e
115 Treatment benefit CMF benefit by recurrence score Survival Tamoxifen CMF Recurrence score
116 When to order Oncotype Dx Newly diagnosed breast cancer Stage I/II, node negative T1N0 or T2N0 ER+ To be treated with Tamoxifen No data on aromatase inhibitors, ER-, or node + patients
117 Rate of Distant Recurrence as a Continuous Function of the Recurrence Score
118 Implications for Therapy Recurrence score of <18 (Low Risk) No benefit from chemotherapy Benefit from tamoxifen Recurrence score of > 31(Hi risk) Large absolute benefit from chemotherapy Absolute increase in DRFS at 10 yrs 27.6%
119 Conclusion Breast cancer is not one disease Biologic markers are being identified that predict response to treatment Therapy is being tailored to specific tumor characteristics, increasing benefit and decreasing risk
120 Go Rockies
What Every General Surgeon Should Know About Breast Cancer
What Every General Surgeon Should Know About Breast Cancer Christina A. Finlayson, MD Associate Professor, Surgery Director, University of Colorado Hospital Breast Center Outline How are we doing in the
More informationRotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
More informationHereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center
Hereditary Multifocal Breast Cancer Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center CASE STUDY 30 year old Ashkenazi Jewish woman Nulliparous Felt
More informationBreast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA
Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for
More informationManagement of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation
Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs Michael Alvarado, MD Associate Professor of Surgery University of California San Francisco Case Study 59 yo woman with new palpable
More informationA Guide to Breast Imaging: The Latest Technology for Screening and Detecting Breast Cancer
A Guide to Breast Imaging: The Latest Technology for Screening and Detecting Breast Cancer Sally Herschorn, MD Associate Professor of Radiology University of Vermont College of Medicine Medical Director
More informationBreast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.
Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are
More informationHAVE YOU BEEN NEWLY DIAGNOSED with DCIS?
HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women
More informationBreast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?
Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Erin I. Lewis, BUSM 2010 Cheri Nguyen, BUSM 2008 Priscilla Slanetz, M.D., MPH Al Ozonoff, Ph.d.
More informationEpidemiology. Breast Cancer Screening, Diagnosis, Biology and Long-Term Follow-Up EDUCATIONAL OBJECTIVES
Cancer Treatment Centers of America Breast Cancer: Screening, Diagnosis, Biology and Long-Term Follow-Up Presented to: Atlantic Regional Osteopathic Conference Presented by: Pamela Crilley, DO Date: April
More informationEvaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003
Evaluation and Management of the Breast Mass Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Common Presentations of Breast Disease Breast Mass Abnormal
More informationChapter 2 Staging of Breast Cancer
Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination
More informationHow To Decide If You Should Get A Mammogram
American Medical Women s Association Position Paper on Principals of Breast Cancer Screening Breast cancer affects one woman in eight in the United States and is the most common cancer diagnosed in women
More informationChanges in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
More informationBreast Cancer Treatment Guidelines
Breast Cancer Treatment Guidelines DCIS Stage 0 TisN0M0 Tamoxifen for 5 years for patients with ER positive tumors treated with: -Breast conservative therapy (lumpectomy) and radiation therapy -Excision
More informationBREAST CANCER RISK ASSESSMENT AND PRIMARY PREVENTION FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1
FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1 Hello, my name is Rachel Jankowitz, I m an assistant professor of medicine in the Division of Hematology Oncology at the University of Pittsburgh
More informationEarly-stage Breast Cancer Treatment: A Patient and Doctor Dialogue
page 1 Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue Q: What is breast cancer, and what type do I have? A: Cancer is a disease in which cells become abnormal and form more cells in
More informationDescription of Procedure or Service. assays_of_genetic_expression_to_determine_prognosis_of_breast_cancer 11/2004 3/2015 3/2016 3/2015
Corporate Medical Policy Assays of Genetic Expression to Determine Prognosis of Breast File Name: Origination: Last CAP Review: Next CAP Review: Last Review: assays_of_genetic_expression_to_determine_prognosis_of_breast_cancer
More informationRecommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who
More informationSurgical guidelines for the management of breast cancer
Available online at www.sciencedirect.com EJSO xx (2009) S1eS22 www.ejso.com Guidelines Surgical guidelines for the management of breast cancer Contents Association of Breast Surgery at BASO 2009 Introduction...
More informationNicole Kounalakis, MD
Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations
More informationPathologic Assessment Of The Breast And Axilla After Preoperative Therapy
Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy W. Fraser Symmans, M.D. Associate Professor of Pathology UT M.D. Anderson Cancer Center Pathologic Complete Response (pcr) Proof
More informationUnderstanding your pathology report
Understanding your pathology report 2 Contents Contents Introduction 3 What is a pathology report? 3 Waiting for your results 4 What s in a pathology report? 4 Information about your breast cancer 5 What
More informationBreast Health Program
Breast Health Program Working together, for your health. Breast Health Program The Breast Health Program at The University of Arizona Cancer Center offers patients a personalized approach to breast cancer,
More informationBreast Cancer. CSC Cancer Experience Registry Member, breast cancer
ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.
More informationWisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics
Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics In Situ Breast Cancer in Wisconsin INTRODUCTION This bulletin provides information
More informationNew Treatment Advances for Breast Cancer
New Treatment Advances for Breast Cancer Guest Expert: Lyndsay, MD Director of the Yale Cancer Center Breast Cancer Program Gina ng, MD www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center
More informationWhen it comes to treating breast cancer, doing less does more October is Breast Cancer Awareness Month
For Immediate Release Oct. 8, 2012 When it comes to treating breast cancer, doing less does more October is Breast Cancer Awareness Month SEATTLE Oncologists and researchers are discovering that when it
More informationUnderstanding ductal carcinoma in situ (DCIS) and deciding about treatment
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre Funded by the Australian Government Department of Health and Ageing Understanding
More informationBREAST CANCER PATHOLOGY
BREAST CANCER PATHOLOGY FACT SHEET Version 4, Aug 2013 This fact sheet was produced by Breast Cancer Network Australia with input from The Royal College of Pathologists of Australasia I m a nurse and know
More informationBreast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.
Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast
More informationAreola: The area of dark-colored skin on the breast that surrounds the nipple.
Glossary of Terms Adenocarcinoma: Cancer arising in gland-forming tissue; the medical term meaning related to a gland is adeno ; breast lobules and ducts are types of glands. Adjuvant: Treatment given
More informationOBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
More informationIntroduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
More informationductal carcinoma in situ (DCIS)
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre
More informationFlorida Breast Health Specialists Breast Cancer Information and Facts
Definition Breast cancer is a cancer that starts in the tissues of the breast. There are two main types of breast cancer: Ductal carcinoma starts in the tubes (ducts) that move milk from the breast to
More informationYour Guide to the Breast Cancer Pathology Report
Your Guide to the Breast Cancer Pathology Report Developed for you by Breastcancer.org is a nonprofit organization dedicated to providing education and information on breast health and breast cancer. The
More informationMale breast cancer - Wikipedia, the free encyclopedia
pagina 1 van 5 Male breast cancer From Wikipedia, the free encyclopedia Male breast cancer is a relatively rare cancer in men that originates from the breast. As it presents a similar pathology as female
More informationwww.downstatesurgery.org
Male Breast Cancer Rabih Nemr MD Kings County Hospital August 2008 ACGME Core Competencies 1 Patient t Care Medical Knowledge 2 g 3 4 Practice Based Learning/Improvement Interpersonal Communication Skills
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationNOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES
NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES GP Referrals All GP referrals for asymptomatic women with a family history of breast and/or
More informationPatient Guide to Breast Cancer Surgery and Treatment
Patient Guide to Breast Cancer Surgery and Treatment Coree H. Flight attendant and mother of 3. Diagnosed with invasive breast cancer in 2009. An educational guide prepared by Genomic Health This Is Your
More informationBreast Density Legislation: Implications for primary care providers
Breast Density Legislation: Implications for primary care providers Deborah J. Rhodes MD Associate Professor of Medicine 2012 MFMER slide-1 Disclosure Relevant financial relationship(s) None Off-label
More informationBreakthrough Treatment Options for Breast Cancer
Breakthrough Treatment Options for Breast Cancer Guest Expert: Lyndsay, MD Associate Professor of Medical Oncology, Yale Cancer Center www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center
More informationThe best treatment Your guide to breast cancer treatment in England and Wales
The best treatment Your guide to breast cancer treatment in England and Wales If you are looking for information on the treatment of secondary breast cancer (also known as advanced or metastatic breast
More informationBreast Cancer Educational Program. June 5-6, 2015
Breast Cancer Educational Program June 5-6, 2015 Adjuvant Systemic Therapy For Early Breast Cancer: Who, What and for How Long? Debjani Grenier MD, FRCPC Medical Oncologist Disclosures Advisory Board Member:
More informationCurrent Status and Perspectives of Radiation Therapy for Breast Cancer
Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic
More informationPROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL
Oncoplastic breast conservation surgery Melvin J Silverstein C H A P T E R 5 Introduction Oncoplastic breast conservation surgery combines oncologic principles with plastic surgical techniques. But it
More informationExamples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.
CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests
More informationGoals and Objectives: Breast Cancer Service Department of Radiation Oncology
Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including
More informationBreast Cancer. The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer.
Breast Cancer What Does the Pathology Report Say Normal Cells The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer. Non-Invasive
More informationOvarian Cancer Genetic Testing: Why, When, How?
Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine
More informationDuctal carcinoma in situ (DCIS)
DIAGNOSIS: DCIS Ductal carcinoma in situ (DCIS) This factsheet gives information on an early form of breast cancer called ductal carcinoma in situ (DCIS). It explains what it is, how your breast is made
More informationPrinciples of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology
Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate Professor Radiation Oncology Disclosure Information I have no financial relationships to disclose relevant to the conten of this presentation.
More informationOne of the most mature trials that examined PROCEEDINGS. Hormone Therapy in Postmenopausal Women With Breast Cancer * William J.
Hormone Therapy in Postmenopausal Women With Breast Cancer * William J. Gradishar, MD ABSTRACT *Based on a presentation given by Dr Gradishar at a roundtable symposium held in Baltimore on June 28, 25.
More informationGuidelines for the treatment of breast cancer with radiotherapy
London Cancer Guidelines for the treatment of breast cancer with radiotherapy March 2013 Review March 2014 Version 1.0 Contents 1. Introduction... 3 2. Indications and dosing schedules... 3 2.1. Ductal
More informationThe Early Detection of Breast Cancer
2007 Update Administered by the Alberta Guideline for Medical Association The Early Detection of Breast Cancer This guideline was written to provide guidance about the appropriate use of screening tools
More informationBREAST CANCER IN THE 21 st CENTURY. The Carolinas Medical Center NorthEast Experience. Garry Schwartz, MD
BREAST CANCER IN THE 21 st CENTURY The Carolinas Medical Center NorthEast Experience Garry Schwartz, MD The American Cancer Society's most recent estimates for breast cancer in the United States for 2009
More informationBreast Health Starts Here
Breast Health Starts Here k Breast Health Knowledge and self-awareness are powerful tools. Understanding and utilizing these tools starts with Lake Charles Memorial s Breast Health Program. Developing
More informationThe Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine
The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary
More informationUnderstanding Your Surgical Options For Breast Cancer
RADIATION THERAPY SYMPTOM MANAGEMENT CANCER INFORMATION Understanding Your Surgical Options For Breast Cancer In this booklet you will learn about: Role of surgery in breast cancer diagnosis and treatment
More informationThe best treatment Your guide to breast cancer treatment in Scotland
The best treatment Your guide to breast cancer treatment in Scotland If you are looking for information on secondary breast cancer treatment, please see Breast Cancer Now s website: breastcancernow.org/
More informationASTRO Spring Refresher Course 2013: Early Breast Cancer
ASTRO Spring Refresher Course 2013: Early Breast Cancer Eleanor Harris, MD Professor and Chair Department of Radiation Oncology Brody School of Medicine East Carolina University Objectives: Early Breast
More informationBreast Cancer. Treatment Guidelines for Patients
Breast Cancer Treatment Guidelines for Patients Version IX/ July 2007 Current ACS-NCCN Treatment Guidelines for Patients Advanced Cancer and Palliative Care Treatment Guidelines for Patients (English and
More informationGuide to Understanding Breast Cancer
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
More informationOutline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
More informationBreast Cancer. Presentation by Dr Mafunga
Breast Cancer Presentation by Dr Mafunga Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop breast cancer It most commonly affects women over
More informationWhat is breast cancer?
Breast Cancer What is breast cancer? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines BREAST CANCER: A GUIDE FOR
More informationSUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
More informationdedicated to curing BREAST CANCER
dedicated to curing BREAST CANCER When you are diagnosed with breast cancer, you need a team of specialists who will share their knowledge of breast disease and the latest treatments available. At Cancer
More informationBreast Cancer Screening
Breast Cancer Screening Summary of the Clinical Practice Guideline September 2013 These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate
More informationLoco-regional Recurrence
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer AGO AGO e. e. V. V. Loco-regional Recurrence Loco-regional Recurrence Version 2002: Brunnert / Simon Versions 2003 2012: Audretsch
More informationAmerican Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography Debbie Saslow, PhD; Carla Boetes, MD, PhD; Wylie Burke, MD, PhD; Steven Harms, MD; Martin O. Leach, PhD; Constance
More informationNon-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines
Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James
More informationHereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center
Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary
More informationCRICO Breast Care Management Algorithm
CRICO Breast Care Management Algorithm A DECISION SUPPORT TOOL Created: 1995 Revised: 2000, 2003, 2010 Current: 2014 Warm Gray 10 PC: 20c 29m 28y 56k 7417 PC: 0c 80m 80y 0k Improving Breast Patient Safety
More informationGuideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer
Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Version History Version Date Summary of Change/Process 0.1 09.01.11
More informationBreast Cancer Treatment: A Multidisciplinary Approach Maihgan Kavanagh, MD, MPH Kaiser Santa Clara Medical Center
Breast Cancer Treatment: A Multidisciplinary Approach Maihgan Kavanagh, MD, MPH Kaiser Santa Clara Medical Center Santa Clara Medical Center What is Multidisciplinary Breast Cancer Care? An integrated
More informationElioTanaka, MD, Medical Oncology, Audit Medical in Health Service, Curitiba s Health Institute, Paraná, Brazil. www.isaebrasil.com.
IP2: The cost-effectiveness of breast magnetic resonance imaging (MRI) to detect a locoregional recurrence in patients with breast conserving therapy. Is it feasible in Latin America? www.isaebrasil.com.br
More informationScreening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group
Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection
More informationArticles. Early Breast Cancer Trialists Collaborative Group (EBCTCG)* www.thelancet.com Vol 366 December 17/24/31, 2005 2087
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists
More informationCancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.
Underwriting cancer In this issue of the Decision, we provide an overview of Canadian cancer statistics and the information we use to make an underwriting decision. The next few issues will deal with specific
More informationBRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet
BRCA Genes and Inherited Breast and Ovarian Cancer Patient information leaflet This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could
More informationBreast Cancer and Treatment
PATIENT EDUCATION patienteducation.osumc.edu Breast cancer affects nearly 200,000 women each year in the United States. The risk of developing breast cancer over a lifetime is 1 in 8, or 12%. Breast cancer
More informationNational Cancer Institute. What You Need TM. To Know About. Breast Cancer. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health
National Cancer Institute What You Need TM To Know About Breast Cancer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Services This is only one of
More informationOvarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health
Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public
More informationBREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt
Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years
More informationUnderstanding. Breast Changes. National Cancer Institute. A Health Guide for Women. National Institutes of Health
National Cancer Institute Understanding Breast Changes A Health Guide for Women U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health It was easier to talk with my doctor after reading
More informationNancy E. Davidson, MD Johns Hopkins University. Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationBreast Cancer Care & Research
Breast Cancer Care & Research Professor John FR Robertson University of Nottingham Nottingham City Hospital Breast Cancer (BC) 15,000 BC deaths in the UK each year 20% female cancer deaths 5% all female
More informationIf you have questions about DCIS, call the Cancer Prevention and Treatment Fund s DCIS hotline at 202-223-4000 or write us at info@stopcancerfund.
This free booklet was developed and produced by the Cancer Prevention and Treatment Fund CFC # 11967 If you have questions about DCIS, call the Cancer Prevention and Treatment Fund s DCIS hotline at 202-223-4000
More informationEffects of Herceptin on circulating tumor cells in HER2 positive early breast cancer
Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine
More informationMammography. What is Mammography?
Scan for mobile link. Mammography Mammography is a specific type of breast imaging that uses low-dose x-rays to detect cancer early before women experience symptoms when it is most treatable. Tell your
More informationManagement of Common Breast Problems 2013-2014
Management of Common Breast Problems 2013-2014 T. Kearney, L. Kirstein Objectives 1. To develop a differential diagnosis and a management plan for a woman with a palpable breast mass. 2. To develop a management
More informationHow TARGIT Intra-operative Radiotherapy can help Older Patients with Breast cancer
How TARGIT Intra-operative Radiotherapy can help Older Patients with Breast cancer Jeffrey S Tobias, Jayant S Vaidya, Frederik Wenz and Michael Baum, University College Hospital, London, UK - on behalf
More informationInfrared Thermography Not a Useful Breast Cancer Screening Tool
Contact: Jeanne-Marie Phillips Sharon Grutman HealthFlash Marketing The American Society of Breast Surgeons 203-977-3333 877-992-5470 Infrared Thermography Not a Useful Breast Cancer Screening Tool Mammography
More informationQuestions and answers on breast cancer A guide for women and their physicians
Canadian Breast Cancer Initiative Questions and answers on breast cancer A guide for women and their physicians 2nd edition Based on The Canadian Clinical Practice Guidelines for the Care and Treatment
More informationBreast Cancer. Treatment Guidelines for Patients
Breast Cancer Treatment Guidelines for Patients Version VIII/ September 2006 Current ACS/NCCN Treatment Guidelines for Patients Advanced Cancer and Palliative Care Treatment Guidelines for Patients (English
More informationWhat You Need to Know Before Treatment About: Breast Cancer
What You Need to Know Before Treatment About: Breast Cancer Publication MDCH-1234 Revised: September 2008 Authority: Public Act 368 of 1978, as amended by Public Act 195 of 1986 and Public Act 15 of 1989.
More informationBreast cancer: Diagnosis and complex treatment. Ibolya Czegle MD PhD Semmelweis University 3rd Department of Internal Medicine
Breast cancer: Diagnosis and complex treatment Ibolya Czegle MD PhD Semmelweis University 3rd Department of Internal Medicine Epidemiology Worldwide, breast cancer is the most frequently diagnosed life-threatening
More information